Screener
Nurix Therapeutics, Inc. NRIX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Nurix Therapeutics, Inc.’s reported figures.
The source filing: Nurix Therapeutics, Inc.’s 10-Q, filed July 9, 2026. Open the filing →
- Filed
- Jul 9, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001549595-26-000040
FAQ
- What is Nurix Therapeutics, Inc.'s free cash flow?
- Nurix Therapeutics, Inc. (NRIX) reported free cash flow of -$98.51M in Q1 2026.
- How has Nurix Therapeutics, Inc.'s free cash flow changed year-over-year?
- Nurix Therapeutics, Inc.'s free cash flow decreased by 49.6% year-over-year, from -$65.84M to -$98.51M.
- What is the long-term trend for Nurix Therapeutics, Inc.'s free cash flow?
- Over 3 years (2021 to 2025), Nurix Therapeutics, Inc.'s free cash flow has grown at a 43.0% compound annual growth rate (CAGR), from -$90.03M to -$263.47M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Nurix Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude